Key Statistics for 4552
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4552
- Net Income (M/JPY)
JCR Pharmaceuticals Co., Ltd. develops, produces, and sells pharmaceutical products and raw materials. The Company also sells equipment for hospital and laboratory use. JCR Pharmaceuticals' products include drug for leukemic diseases and hormonal agents including genetically engineered human somatotrophic hormone (growth hormone) and gonadotropic hormone.
More Company Profile & Key Executives for 4552
|Shin AshidaChairman/President/CEO/COO||Katsuro OhnoSenior Managing Director|
|Satoshi MantaniManaging Director||Katsuya NishinoManaging Director|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.